![]() |
|
|
Vol. 287, Issue 1, 416-424, October 1998
Department of Veterinary and Comparative Anatomy, Physiology and
Pharmacology, Washington State University, Pullman, Washington
The Ang IV receptor, AT4, has been shown to play important
roles in various mammalian tissues. In this study, structural
properties of the AT4 receptor from bovine adrenals are
described using a novel photoactive analog of Ang IV,
[125I]Benzoylphenylalanine-Ang IV (BP-Ang IV), recently
developed in our laboratory. [125I]BP-Ang IV is identical
to Ang IV with regards to binding specificity and affinity and is
easily cross-linked to the AT4 receptor under UV light,
thus greatly facilitating the structural analysis of the
AT4 receptor by SDS-PAGE. Comparisons between the native, reduced and nonreduced forms of the AT4 receptors by
SDS-PAGE revealed that this receptor consists of multiple subunits. The subunit containing the Ang IV binding site (designated as the alpha subunit) has a molecular weight of ~165 kDa and
contained ~20% N-linked carbohydrates. A subunit similar to the
adrenal alpha subunit of the AT4 receptor
was identified in all of the bovine tissues examined. Hippocampus and
aorta contained additional [125I]BP-Ang IV bound protein
bands with molecular weights of 150 and 125 kDa, respectively. Further,
the alpha subunit was purified to homogeneity using a
method that integrates electrofractionation with conventional protein
purification techniques.
This article has been cited by other articles:
![]() |
K. M. Gauthier, D. X. Zhang, E. M. Edwards, B. Holmes, and W. B. Campbell Angiotensin II Dilates Bovine Adrenal Cortical Arterioles: Role of Endothelial Nitric Oxide Endocrinology, August 1, 2005; 146(8): 3319 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 205 - 211. [Abstract] [Full Text] |
||||
![]() |
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden Cellular targets for angiotensin II fragments: pharmacological and molecular evidence Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 195 - 204. [Abstract] [PDF] |
||||
![]() |
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF] |
||||
![]() |
J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. HANDA Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449. [Abstract] [Full Text] |
||||
![]() |
B. P. Rowe and B. Dixon Angiotensin III Depressor Action in the Conscious Rabbit Is Blocked by Losartan but not PD 123319 Hypertension, January 1, 2000; 35(1): 130 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, J. W. Harding, and S. M. Simasko Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249. [Abstract] [Full Text] |
||||
![]() |
J.-H. Zhang, J. M. Hanesworth, M. F. Sardinia, J. A. Alt, J. W. Wright, and J. W. Harding Structural Analysis of Angiotensin IV Receptor (AT4) from Selected Bovine Tissues J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1075 - 1083. [Abstract] [Full Text] |
||||